Yay Or Nay On This New Gene Therapy Play?

We look at a small gene therapy concern that recently IPO’d. Is it a Buy?

Today we look at a small biotech concern that is headquarted across the pond in England. This emerging gene therapy concern just hit the public markets late last summer. Given that, this name is…


Fresh Conversations